-
Clinical Pharmacology: Advances and Applications
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
A comparative study of DNA damage in patients suffering from diabetes and thyroid dysfunction and complications
Original Research
(1907) Views (467) Full article downloads
Authors: Nima V Thakkar, Sunita M Jain
Published Date September 2010
Volume 2010:2 Pages 199 - 205
DOI: http://dx.doi.org/10.2147/CPAA.S11366
Nima V Thakkar, Sunita M Jain
Department of Pharmacology, L.M. College of Pharmacy, Ahmedabad, Gujarat, India
Objective: The apoptotic DNA levels in blood leukocytes of patients with type 2 diabetes (T2D) and thyroid dysfunction were evaluated.
Materials and methods: Single-cell gel electrophoresis (comet assay) detects migration of DNA from individual cell nuclei following alkaline treatment. Comet assay pattern was studied in individuals with T2D, hypothyroid (HT), hyperthyroid (HeT), and patients suffering from both diabetes mellitus and HT (HT + DM). Results were compared with the normal subjects (n = 9 in each group). The percentage apoptotic cells were calculated from the tail length.
Results: T2D patients showed 92.24% of cell damage compared to HT or HeT patients (51.04% or 54.64%, respectively). Further, increase in cell damage was also observed in HT + DM subjects (P < 0.05). Pharmacologic therapy significantly influenced cell damage. However, age and duration of disease did not show any definite influence on apoptosis.
Conclusion: Dependence of disease seems to be the major contributor of the cell damage. However, thyroid dysfunction did not show any deleterious effects on individual cells under the study.
Keywords: comet assay, type 2 diabetes, hypothyroid, apoptosis
Readers of this article also read:
Wine consumers’ environmental knowledge and attitudes: Influence on willingness to purchase
Age-related disruption of the lamina dura: Evidence in the mandibular horizontal incompletely impacted third molar
Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility
Clinicoradiological features of recurrent ischemic stroke: healthcare for poststroke patients
Mitochondrial therapy for Parkinson’s disease: Neuroprotective pharmaconutrition may be disease-modifying
Analgesic efficacy of oral gabapentin added to standard epidural corticosteroids in patients with failed back surgery
Wine fraud
Using systematically observed clinical encounters (SOCEs) to assess medical students’ skills in clinical settings
Examining human rights and mental health among women in drug abuse treatment centers in Afghanistan
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- The benefits and risks of testosterone replacement therapy: a review
- Tenofovir-associated bone density loss
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses




